Genetic modifiers of cognitive maintenance among older adults. by Yokoyama, Jennifer S et al.
UCLA
UCLA Previously Published Works
Title
Genetic modifiers of cognitive maintenance among older adults.
Permalink
https://escholarship.org/uc/item/8rq211tw
Journal
Human brain mapping, 35(9)
ISSN
1065-9471
Authors
Yokoyama, Jennifer S
Evans, Daniel S
Coppola, Giovanni
et al.
Publication Date
2014-09-01
DOI
10.1002/hbm.22494
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Genetic Modifiers of Cognitive
Maintenance Among Older Adults
Jennifer S. Yokoyama,1* Daniel S. Evans,2 Giovanni Coppola,3
Joel H. Kramer,1 Gregory J. Tranah,2 and Kristine Yaffe1,4
1Department of Neurology, Memory and Aging Center, University of California,
San Francisco, California
2California Pacific Medical Center Research Institute, San Francisco,
California
3Department of Neurology and Semel Institute for Neuroscience and Human Behavior,
The David Geffen School of Medicine at University of California Los Angeles,
Los Angeles, California
4Departments of Psychiatry and Epidemiology, University of California, San Francisco and
the San Francisco VA Medical Center, San Francisco, California
r r
Abstract: Objective: Identify genetic factors associated with cognitive maintenance in late life and assess
their associationwith graymatter (GM) volume in brain networks affected in aging. Methods: We conducted
a genome-wide association study of2.4 M markers to identify modifiers of cognitive trajectories in Cauca-
sian participants (N5 7,328) from two population-based cohorts of non-demented elderly. Standardized
measures of global cognitive function (z-scores) over 10 and 6 years were calculated among participants and
mixed model regression was used to determine subject-specific cognitive slopes. “Cognitive maintenance”
was defined as a change in slope of 0 andwas comparedwith all cognitive decliners (slope< 0). In an inde-
pendent cohort of cognitively normal older Caucasians adults (N5 122), top association findings were then
used to create genetic scores to assess whether carrying more cognitive maintenance alleles was associated
with greater GMvolume in specific brain networks using voxel-basedmorphometry. Results: The most sig-
nificant association was on chromosome 11 (rs7109806, P5 7.8 3 1028) near RIC3. RIC3 modulates
activity of a7 nicotinic acetylcholine receptors, which have been implicated in synaptic plasticity and
beta-amyloid binding. In the neuroimaging cohort, carrying more cognitive maintenance alleles was
associated with greater volume in the right executive control network (RECN; PFWE5 0.01). Conclu-
sions: These findings suggest that there may be genetic loci that promote healthy cognitive aging and
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INTRODUCTION
Although significant research has gone into understand-
ing the risk factors and pathological processes of demen-
tias, little is known about factors contributing to cognitive
maintenance throughout aging. It has been suggested that
maintenance of cognitive ability over time involves adapt-
ive changes that compensate for deficits such as reduced
synaptic plasticity [Blau et al., 2011], which naturally occur
with aging [Mauceri et al., 2011; Raz and Rodrigue, 2006].
Factors that globally impact cognition may provide an
alternate therapeutic approach for treating dementia, for
which genetic heterogeneity and environmental risk fac-
tors may be further complicating risk factors [Lee and
Silva, 2009].
The emerging field of imaging genomics provides an
innovative way to identify brain phenotypes associated
with genetic variation [Thompson et al., 2010]. Direct
assessment of the effect of genetic variation on the brain
allows for logical interpretation of results as reflected in
established brain–behavior relationships. We performed
the first genome-wide association study (GWAS) to iden-
tify genetic modifiers of cognitive trajectory in healthy
elderly men and women. Then, to directly assess the clini-
cal relevance of candidate variants, we created genetic
scores using the top 10 single nucleotide polymorphisms
(SNPs) to test whether carrying more protective alleles
was associated with greater gray matter (GM) volume in
an independent group of cognitively normal older adults.
We chose a priori to assess three regions of interest (ROIs)
representing the functional networks subserving cognitive
domains most affected in cognitive aging [Kaup et al.,
2011]: the default mode network (DMN; memory
retrieval), and the right and left executive control networks
(RECN and LECN, respectively; executive function and
working memory) [Montembeault et al., 2012; Tomasi and
Volkow, 2012].
MATERIALS AND METHODS
Participants
Elderly GWAS participants were from two independent
cohorts, the all-female Study of Osteoporotic Fractures
(SOF) [Cummings et al., 1995] and the all-male Osteopor-
otic Fractures in Men (MrOS) [Blank et al., 2005; Orwoll
et al., 2005] Study. SOF is a longitudinal epidemiologic
study of 10,366 community-dwelling women age 65 years
or older, recruited from four study centers located in: Bal-
timore, MD; Minneapolis, MN; Portland, OR; and the
Monongahela Valley near Pittsburgh, PA. Exclusion crite-
ria included a bilateral hip replacement or if women were
unable to walk without assistance. The baseline SOF
exams were conducted from 1986–1988, when 9,704 Euro-
pean American women were recruited [Cummings et al.,
1995; Vogt et al., 2003]. Baseline examination for MrOS
occurred from 2000 to 2002, during which 5,994
community-dwelling men 65 years or older were enrolled
at six clinical centers in the United States: Birmingham,
AL; Minneapolis, MN; Palo Alto, CA; the Monongahela
Valley near Pittsburgh, PA; Portland, OR; and San Diego,
CA [Blank et al., 2005; Orwoll et al., 2005]. To participate,
men needed to be able to walk without assistance and
must not have had a bilateral hip replacement. Individuals
that were related to each other in SOF and MrOS were
identified based on whole genome SNP data and only a
single individual from the related pair was included in the
analysis (the subject with non-missing phenotype data or,
if both members of the related pair had non-missing phe-
notypes, the sample with the lowest SNP missing rate was
retained).
Neuroimaging replication participants (N5 122 Cauca-
sian individuals) were part of on-going healthy aging
studies at the Memory and Aging Center (MAC) at the
University of California, San Francisco (UCSF). Cognitively
normal older adults were recruited through a variety of
methods, primarily through newspaper advertisements
and word-of-mouth and were required to have a knowl-
edgeable informant. Cognitively normal older adults had
MRI scans acquired within 1 year of clinical evaluation,
were self-described Caucasian, and had genotypes avail-
able for analysis. Normal cognition was based on the
absence of cognitive complaints from the participant and
their informant, a normal neurological examination and
clinical dementia rating scale sum of boxes score5 0
[Morris, 1993].
Standard Protocol Approvals, Registrations,
and Patient Consents
All women from SOF provided written informed con-
sent, and the institutional review board at each site
approved the study. All men from MrOS provided written
informed consent, and the institutional review board at
each site approved the study. All MAC participants
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provided written informed consent, and the UCSF institu-
tional review board approved all aspects of this study.
Cognitive Assessment
In SOF, the shortened Mini-Mental State Exam (MMSE)
[Folstein et al., 1975] with a maximum of 26 points was
used to assess global cognitive ability and was adminis-
tered at baseline, years 4, 6, and 10. In MrOS, the Modified
MMSE (3MS) [Teng and Chui, 1987] was administered at
baseline, years 4 and 6. A standard neuropsychological
battery was performed in MAC participants as previously
described [Rankin et al., 2005].
Genotype Acquisition and Quality Control
Genotyping for SOF, MrOS, and MAC participants was
performed on the Illumina Omni1-Quad array genotyping
platform as per manufacturer’s instructions. Genotyping of
SOF and MrOS samples was performed at the Broad Insti-
tute of Harvard and MIT and MAC samples were geno-
typed at the University of California Los Angeles.
Imputation was performed in SOF and MrOS participants
only for all individuals of European American genetic
background (as determined by principal components anal-
ysis), using CEU HapMap Phase 2 data as reference. Of
3,020,488 HapMap Phase 2 imputed SNPs, there were a
total of 2,457,365 SNPs available for meta-analysis
(2,368,637 in SOF and 2,455,897 in MrOS) after excluding
those with MAF< 0.01, Hardy–Weinberg Equilibrium
(HWE) P< 0.001, call rate< 95% and imputation accu-
racy< 0.3. SNPs genotyped in the MAC cohort were simi-
larly required to have MAF> 0.01, HWE P> 0.001, and
call rate> 95% to be included in the genetic score.
Image Acquisition and Preprocessing
Structural images were acquired in MAC samples using
previously described sequences [Sturm et al., 2013] on 3 T
(N5 103) and 1.5 T (N5 19) scanners. T1-weighted struc-
tural MR images were segmented in SPM8 running under
Matlab then preprocessed with DARTEL [Ashburner,
2007] using previously described methods [Ashburner and
Friston, 2000; Wilson et al., 2009]. DARTEL-processed GM
images were then smoothed with an 8-mm kernel. Masks
for each functional network ROI were from a previously
published study (Supporting Information Fig. S1) [Habas
et al., 2009].
Genetic Score
Genetic scores for imaging analysis in MAC samples
were calculated using SNPs from the top 10 findings from
the combined SOF-MrOS GWAS that had genotypes avail-
able in the MAC samples. We arbitrarily chose to survey
the top 10 SNPs because they represented the strongest
genomic candidate regions for cognitive maintenance.
Only the most significantly associated SNP out of sets in
strong linkage disequilibrium (r2> 0.8) were used for anal-
ysis so each independently associated region was repre-
sented once in the score. Scores were weighted by the beta
value from the original GWAS (SOF or MrOS) with the
strongest association P-value for the effect allele (MrOS
for all three SNPs included in the final score). Genetic
scoring was performed in PLINK [Purcell et al., 2007].
Statistical Analysis
Standardized measures of global cognitive function (z-
scores) were calculated for MMSE (SOF) and 3MS (MrOS)
repeated measures. Participant-specific slopes and inter-
cepts for SOF and MrOS participants were calculated
using mixed effect regression models (PROC MIXED in
SAS, SAS Institute, Cary, NC). Mixed effect regression ena-
bles estimation of population-level fixed effects (overall
rate of change in cognitive function in the entire sample)
and individual-level random effects (individual deviation
from the overall group pattern). Our models allow each
participant to have a unique intercept and trajectory
(change in cognitive function). Fixed effects included site,
age and education. “Cognitive maintenance” was defined
as a change in global cognitive function over time (slope)
of 0.
GWAS of SOF and MrOS were performed in each cohort
separately using logistic regression in R (v2.13.0) that cor-
rected for population substructure with the first four prin-
cipal components. Results were then combined via fixed
effect meta-analysis with inverse variance weights and
genomic control in METAL [Willer et al., 2010] and are
presented as the final analysis. Heterogeneity between
sexes was tested using GWAMA [Magi et al., 2010; Magi
and Morris, 2010].
For VBM analysis, a voxel-wise general linear model
(GLM) was conducted within each of the a priori defined
ROIs (Supporting Information Fig. S1). The GLM modeled
genetic score as a predictor of GM volume and included
as nuisance variables age, total intracranial volume (TIV),
sex, scan type (1.5 T or 3 T), education (years), handedness
(N5 107 right, N5 15 left/ambidextrous) and number of
APOE e4 alleles (0 [N5 91], 1 [N5 26], or 2 [N5 5]). To
adjust for multiple testing, 1,000 permutation analyses
combining cluster peak intensity and extent were used
[Hayasaka and Nichols, 2004]. Permutation analysis is a
resampling approach that allows derivation of a study-
specific error distribution from which the one-tailed T-
threshold representing a family-wise error (FWE) correc-
tion of PFWE< 0.05 can be established [Kimberg et al.,
2007]. To quantify neuroimaging findings, mean GM pro-
portion (a proxy of volume) was extracted for each cluster,
summed across the ROI, and adjusted for the same nui-
sance variables included in the VBM linear model. Analy-
sis was run using vlsm2.5 [Bates et al., 2003].
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RESULTS
A total of 3,508 women and 3,820 men had genetic data,
 2 cognitive test scores available, and were of European
ancestry and unrelated for inclusion in the GWAS analysis.
Of the 3,508 SOF participants, 781 (22.3%) women were cog-
nitive maintainers. Maintainers were around the same age
as decliners (mean6 SD 71.36 4.9 years versus 71.56 5.4
years in decliners, P5 0.25), but tended to have lower educa-
tion (12.06 2.3 versus 12.86 2.9 in decliners, P< 0.0001) and
higher baseline MMSE scores (25.16 1.2 versus 24.66 1.7 in
decliners, P< 0.0001). In MrOS, 222 (5.8%) of 3,820 men
were cognitive maintainers and they tended to be older
(75.56 5.5 years versus 73.96 6.0 years, P5 0.002), have
lower education (61.7% versus 77.5% with greater than 12
years education, P< 0.0001) and higher baseline 3MS scores
(95.16 3.8 versus 93.56 5.5, P5 0.0002).
Top ten findings from the SOF and MrOS combined
GWAS identified six different genes/regions associated
with cognitive maintenance (Table I). The most significant
association was an intergenic SNP on chromosome 11,
rs7109806 (P5 7.8 3 1028), which nearly reached genome-
wide significance (P< 5 3 1028). Four of the top 10 SNPs
were located within the coding region of MTNR1B, a high-
affinity melanocortin receptor expressed primarily in brain
and retina. Q–Q plots for the GWAS are shown in
Supporting Information Figure S2.
To evaluate the clinical relevance of our top 10 cognitive
maintenance GWAS findings, we created genetic scores
representing “dose” of cognitive maintenance alleles and
assessed their association with GM volume in an inde-
pendent group of 122 cognitively normal older adults
(MAC cohort: 68.96 7.0 years old, 58.2% female, 17.36 2.1
years of education). We were specifically interested in
assessing whether carrying more cognitive maintenance
alleles was associated with greater volume in functional
networks underlying cognitive domains most vulnerable
to aging. We arbitrarily chose to survey the top 10 SNPs
for their clinical relevance. Three independent SNPs repre-
senting three of the six genes in the top 10 findings had
been genotyped in the MAC cohort and were used to cre-
ate the genetic score (SNPs included in the scoring are
marked byb in Table I). Higher genetic score was signifi-
cantly associated with greater GM volume in three regions
of the RECN (PFWE5 0.01–0.03, Fig. 1, Table II). A plot of
the sum of the volume of these three RECN regions as a
function of genetic score is shown in Supporting Informa-
tion Figure S3. No regions in the DMN or regions in the
LECN not overlapping with the RECN demonstrated any
significant findings (Praw> 0.001).
Using a simplified scoring scheme, we plotted the sum
of the volumes of the three regions within the RECN as a
function of the number of cognitive maintenance alleles to
determine the average increase in GM volume with each
“dose” of putative protective allele (Fig. 2). There were
N5 24 with no alleles, N5 35 with one allele, N5 38 with
two alleles, N5 21 with three alleles and N5 4 with four
alleles. No individuals had more than four cognitive
maintenance-associated alleles. After normalizing to vol-
ume in individuals with no maintenance alleles, we
observed a dose-dependent effect with an average of 6%
greater volume for each additional cognitive maintenance
allele. Although the majority of individuals carried two
protective alleles, individuals with three or four showed
approximately 20%–25% greater volume, when compared
to those with no alleles.
DISCUSSION
Our GWAS of cognitive maintenance in over 7,000
elderly, community-dwelling men and women yielded an
association with variant rs7109806 with a P-value close to
genome-wide significance. In an independent cohort, we
TABLE I. Top meta-analysis findings for cognitive maintenance from SOF and MrOS
SNP Chr BP Nearest gene A1 A2 MAF Imp HWE N Beta [SE]a P value
rs7109806b 11 8199205 RIC3 T C 0.09 N 0.47 7,328 20.75 [0.14] 7.80 E 208
rs6578942 11 8199746 RIC3 T C 0.09 N 0.56 7,328 20.72 [0.15] 7.96 E 208
rs2460141 15 74319900 PML C G 0.01 Y 3,820 22.19 [0.43] 4.93 E 207
rs7814474 8 81222009 TPD52 C G 0.04 Y 7,328 20.97 [0.22] 1.81 E 206
rs7918950b 10 70678711 DDX50 A G 0.22 Y 7,328 20.54 [0.13] 2.17 E 206
rs9428707 1 236282325 GPR137B A C 0.01 Y 3,820 21.71 [0.37] 3.13 E 206
rs2605578 11 92782276 MTNR1B T C 0.50 Y 7,328 20.44 [0.10] 3.54 E 206
rs11020267b 11 92698003 MTNR1B A G 0.39 N 0.05 7,328 20.36 [0.10] 4.11 E 206
rs11020270 11 92700892 MTNR1B C G 0.39 Y 7,328 20.37 [0.10] 4.12 E 206
rs10831025 11 92696418 MTNR1B T C 0.39 N 0.07 7,328 20.36 [0.10] 4.61 E 206
aEffect sizes are provided for the MrOS GWAS and were used to calculate the genetic scores. Chr—chromosome; BP—base position;
A1—reference allele; A2—alternate allele; MAF—minor allele frequency for A2; imp—imputed SNP (Yes/No); HWE—Hardy-Weinberg
Equilibrium P-value for genotyped SNP; N—total number of individuals available for meta-analysis of SOF1MrOS GWAS; Beta [SE]—
beta6 standard error from MrOS GWAS.
bIndicates SNP was used to calculate the genetic score for VBM analysis.
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found that higher cognitive maintenance genetic scores
derived from this and two other top 10 SNPs were associ-
ated with greater volume in the RECN, a functional net-
work associated with working memory, attention and task
control. By plotting volume of the RECN by number of
cognitive maintenance allele, we observed a dose-
dependent increase such that individuals with three alleles
had an average of 20% greater volume compared to those
Figure 1.
Higher cognitive maintenance genetic scores are associated with greater GM volume in RECN.
VBM T-map overlaid on slices of template used for image processing in MRIcron, thresholded at
Praw< 0.001. Images are in neurological orientation, with MNI coordinates provided below. 3D
renders are visualized on a normal template brain in Connectome Workbench.
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with no alleles. This suggests that the effect of carrying
alleles associated with cognitive maintenance may be quite
significant.
Our top SNP is located between RIC3 and LMO1. It is
possible that this intergenic polymorphism affects a non-
coding gene element such as a transcription factor binding
site or enhancer, or that this variant alters epigenetic mod-
ification of the region. Alternatively, it may tag other,
functional variants in a neighboring gene. RIC3 is a tempt-
ing gene candidate; RIC3 modulates activity of nicotinic
acetylcholine receptors (nAChRs), which have been impli-
cated in synaptic plasticity. RIC3 enhances surface expres-
sion and functional properties of nAChRs, including the
a7 subtype [Treinin, 2008] which has high affinity for amy-
loid beta (Ab) 1–42 [Wang et al., 2000]. Ab1–42 is a neuro-
toxic, self-associating peptide that contributes to formation
of amyloid plaques in Alzheimer’s disease (AD) [Lambert
et al., 1998]. Four other genes in the top findings were pre-
viously implicated in other GWAS: PML in myopia [Meng
et al., 2012], Paget’s disease [Albagha et al., 2011], and
height [Lango Allen et al., 2010]; TPD52 in monoamine
metabolite levels in cerebrospinal fluid [Luykx et al., 2013];
GPR137B in working memory in response to olanzapine
treatment in schizophrenia [McClay et al., 2011]; MTNR1B
for multiple metabolic- and glucose-related phenotypes
(e.g., fasting glucose [Prokopenko et al., 2009]; metabolic
traits [Sabatti et al., 2009]). In addition to RIC3, MTNR1B
is a particularly intriguing candidate given the role meta-
bolic syndrome may play in risk for cognitive decline
[Arvanitakis et al., 2004; Baker et al., 2011; Panza et al.,
2010; Yaffe, 2007a, b]. Further mapping studies will be
required to assess these candidates for causative non-
coding or gene variation in cognitive maintenance.
Genetic risk factors for AD such as APOE e4 may also
modify cognitive trajectories in healthy aging [Caselli et al.,
2007, 2012; Sweet et al., 2012]. There were 123 SNPs associ-
ated with AD and its related phenotypes in the NHGRI
Catalog of Published GWAS and representing the APOE/
TOMM40/APOC1 linkage block (19q13-q13.2 chromosomal
region [Jun et al., 2012; Seripa et al., 2012]) also included in
our analysis of cognitive maintenance. Of these, 12 had
P< 0.05 in our GWAS. The lowest P-value was at rs4420638
(P5 3.13 3 1025) that tags the APOE/TOMM40/APOC1
region and was identified in a GWAS of AD risk in
European ancestry individuals [Kamboh et al., 2012b].
Additional genes represented included PVRL2 [Ramanan
et al., 2013], HRK, RNFT2 [Kamboh et al., 2012a], DISC1
[Beecham et al., 2009], POLN [Logue et al., 2011], and
ZNF320 [Hollingworth et al., 2012]. However, there were 86
other SNPs in our analysis that demonstrated stronger asso-
ciations with cognitive maintenance than the top AD SNP
representing APOE/TOMM40/APOC1. This suggests that
genetic variation associated with AD likely plays a lesser
role in cognitive maintenance.
Our study benefited from a large cohort of well-
characterized older adults who have been followed longi-
tudinally, allowing for a sophisticated measure of cogni-
tive maintenance over time. In addition, our novel
research approach allowed us to directly assess the biolog-
ical validity of our candidate SNPs in the context of a clin-
ically oriented research study of healthy aging. We
acknowledge that the use of a binary cutoff for cognitive
maintenance may lead to misclassification of some subjects
TABLE II. VBM findings
Region Volume (mm3) Max T X Y Z PFWE
Right precuneus 942 3.77 12 255 22 0.01
Right angular gyrus 854 4.80 30 251 34 0.01
Right middle frontal gyrus 381 3.87 30 8 54 0.03
Regions are annotated using the Anatomical Automatic Labeling atlas. Max T—maximum T-score for the cluster; X, Y, Z—Montreal
Neurological Institute coordinates; PFWE—family-wise error adjusted P-value.
Figure 2.
Proportional increase in volume by number of cognitive mainte-
nance alleles. Volume in RECN is shown by number of cognitive
maintenance alleles, normalized to value for no alleles. Data is
mean6 SE adjusted for age, sex, education, TIV, scan type, hand-
edness, and APOE e4 allele count.
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based on their true underlying change. However, results
ignoring misclassification errors in binary outcomes lead
to attenuation of effect estimates and likely loss of power
to detect true association findings [Neuhaus, 1999]. Use of
frameworks incorporating imaging and genetic analysis
into one model may provide better-powered analysis in
future studies [Batmanghelich et al., 2013]. Other limita-
tions of this study included having different proportions
of cognitive maintainers in the SOF and MrOS cohorts and
somewhat insensitive cognitive battery. Indeed, the pro-
portion of cognitive maintainers was higher in the female
SOF cohort. The top five associated SNPs analyzed in both
cohorts demonstrated significant heterogeneity between
sexes (P< 0.05); while effects in each cohort were always
in the same direction, they were on average 2.53 higher
in MrOS versus SOF. This observation may represent a
biological phenomenon, though it may also be a survival
effect because the males were on average older than the
females.
In this study, we used a genome-wide survey to identify
candidate genes that may play a role in cognitive mainte-
nance by promoting GM robustness in areas of the brain
important for executive function. Taking an imaging
genomics approach of assessing genetic scores derived
from top GWAS findings for their association with GM
volume may represent a clinically relevant measure of
how genetic variation affects brain structure and, ulti-
mately, function. We feel the strength of our GWAS find-
ings and their ability to predict greater volume in brain
regions important for cognitive domains vulnerable in
aging [Hinman and Abraham, 2007] provide compelling
evidence for a role in cognitive maintenance. Previous
findings associating polygenic AD risk scores with cortical
thickness in regions of the brain most affected in AD in
healthy older adults [Sabuncu et al., 2012] further suggest
these results are of clinical relevance. The use of composite
genetic and imaging biomarkers improves predictions of
AD progression [Filipovych et al., 2012] and suggests that
complementary studies of cognitive maintenance genetic
variants and anatomical correlates may be useful in identi-
fying individuals most likely to experience successful cog-
nitive aging. Similar to studies of brain regions affected in
AD, multimodal studies of longitudinal change in RECN
volume may also allow for identification of additional
gene modifiers [Vounou et al., 2012] and functional path-
ways [Silver et al., 2012] that promote healthy cognition in
aging. Future studies will be required to generalize these
findings to diverse populations and to directly assess
whether they have a modifying role in disease risk, trajec-
tory, and outcome.
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